IRB Role In Clinical Trials Registries Should Be Limited To Checking Documentation, White Paper Suggests
This article was originally published in The Pink Sheet Daily
Executive Summary
Making institutional review board approval of clinical studies contingent on placement of a study in a clinical trial registry would be an effective mechanism to enforce registry requirements, but the IRB role should be limited to verifying that the study has been submitted, the Fordham Center for Ethics Education suggests in a Sept. 2 white paper.